Results

Mitsubishi Tanabe Pharma Corporation

11/11/2019 | Press release | Distributed by Public on 11/10/2019 20:23

HIF-PH Inhibitor Vadadustat (MT-6548) Japan Phase 3 results for the treatment of renal anemia at American Society of Nephrology, Kidney Week 2019